Fulgent Genetics (FLGT) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Fulgent Genetics (FLGT) has outperformed Exagen (XGN) over the past year, losing 8.8% versus a loss of 25.6%. Over five years, XGN leads with a -35.3% price change compared with -73.3% for FLGT. Fulgent Genetics is the larger company by market cap ($572.9 million vs $197.9 million), about 2.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLGT | XGN |
|---|---|---|
| Share price | $20.82 | $8.17 |
| Market cap | $572.87M | $197.92M |
| 1-day change | +1.22% | -1.57% |
| YTD return | -20.75% | +34.38% |
| 1-year return | -8.80% | -25.59% |
| 5-year return | -73.31% | -35.31% |
| EPS (TTM) | $-2.82 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.04 | $12.23 |
| 52-week low | $13.46 | $2.59 |
| Distance from 52-week high | -32.93% | -33.20% |
| Analyst consensus | none | none |
| Avg. price target upside | -8.74% | +24.11% |
| Average volume | 301.04K | 328.42K |
| Shares outstanding | 27.52M | 24.23M |
| Employees | 1,315 | 216 |
| Sector | Healthcare | Health Care |
| Industry | Diagnostics & Research | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fulgent Genetics is about 2.9 times larger than Exagen by market value ($572.87M vs $197.92M).
- FLGT has outperformed XGN by 16.8 percentage points over the past year.
- The two companies sit in different sectors: Fulgent Genetics in Healthcare and Exagen in Health Care.
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Healthcare · Diagnostics & Research · 1,315 employees
About Exagen
XGN stock →Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Health Care · Medical Specialities · 216 employees
FLGT vs XGN FAQ
Which is bigger, Fulgent Genetics or Exagen?
Fulgent Genetics (FLGT) is larger, with a market capitalization of $572.87M compared with $197.92M for Exagen (XGN).
Which stock has performed better over the past year, FLGT or XGN?
FLGT returned -8.80% over the past 12 months, compared with -25.59% for XGN (price return, excluding dividends). Past performance does not predict future results.
Are Fulgent Genetics and Exagen in the same industry?
No. Fulgent Genetics is in the Healthcare sector, while Exagen is in Health Care.